Microdoses" of lysergic acid diethylamide (LSD) are used recreationally to enhance mood and cognition. Increasing interest has also been seen in developing LSD into a medication. Therefore, we performed a pharmacokineticpharmacodynamic study using very low doses of LSD. Single doses of LSD base (5, 10, and 20 µg) and placebo were administered in a double-blind, randomized, placebo-controlled crossover study in 23 healthy participants. Test days were separated by at least 5 days. Plasma levels of LSD and subjective effects were assessed up to 6 hours after administration. Pharmacokinetic parameters were determined using compartmental modeling. Concentrationsubjective effect relationships were described using pharmacokinetic-pharmacodynamic modeling. Mean (95% confidence interval) maximal LSD concentrations were 151 pg/mL (127-181), 279 pg/mL (243-320), and 500 pg/ mL (413-607) after 5, 10, and 20 µg LSD administration, respectively. Maximal concentrations were reached after 1.1 hours. The mean elimination half-life was 2.7 hours (1.5-6.2). The 5 µg dose of LSD elicited no significant acute subjective effects. The 10 µg dose of LSD significantly increased ratings of "under the influence" and "good drug effect" compared with placebo. These effects began an average of 1.1 hours after 10 µg LSD administration, peaked at 2.5 hours, and ended at 5.1 hours. The 20 µg dose of LSD significantly increased ratings of "under the influence," "good drug effects," and "bad drug effects." LSD concentrations dose-proportionally increased at doses as low as 5-20 µg and decreased with a half-life of 3 hours. The threshold dose of LSD base for psychotropic effects was 10 µg. Lysergic acid diethylamide (LSD) is a well-known classic serotonergic psychedelic that is widely used for recreational purposes. 1 LSD is well-absorbed, 2,3 and maximal LSD concentrations are reached 1.5-2 hours after oral administration. 4 LSD is mainly metabolized to inactive O-H-LSD, which is renally eliminated. 3 The plasma half-life of LSD is 3-4 hours. 3,4 Increasing interest has been seen in using LSD for the treatment of various disorders, including depression and anxiety, 5 substance use, 6 and cluster headache, 7 among others. 8 LSD "microdosing" has recently become popular. 9,10 The practice of microdosing refers to the use of very low doses of LSD that are taken at 2-to-5-day intervals to improve cognitive function and mood. 11-13 However, little is known about the effects of very low doses of LSD. More data are needed to